Evidence map›Paper›PMID 28315615›Full record

ArticleNeoplasia (New York, N.Y.)2017

MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular Protection and Tumorigenesis.

Sanjay Yadav, Nishant Singh, Parag P Shah, David A Rowbotham, Danial Malik, Ankita Srivastav, Jai Shankar, Wan L Lam, William W Lockwood, Levi J Beverly

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. miR-155: An Important Role in Inflammation Response.Journal of immunology research · 2022
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Sanjay YadavJames Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202; CSIR-Indian Institute of Toxicology Research, Lucknow, UP 226001, India. Electronic address: sanjay@iitr.res.in.
Nishant SinghCSIR-Indian Institute of Toxicology Research, Lucknow, UP 226001, India. Electronic address: Nishant.Singh@iitr.res.in.
Parag P ShahJames Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202. Electronic address: Parag.Shah@Louisville.edu.
David A RowbothamIntegrative Oncology, British Columbia Cancer Agency, Vancouver, B.C., Canada V5Z 1L3. Electronic address: Drowbotham@bccrc.ca.
Danial MalikJames Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202. Electronic address: Danial.Malik@Louisville.edu.
Ankita SrivastavCSIR-Indian Institute of Toxicology Research, Lucknow, UP 226001, India. Electronic address: AnkitaBiochem@gmail.com.
Jai ShankarCSIR-Indian Institute of Toxicology Research, Lucknow, UP 226001, India. Electronic address: Jai.Shankar@iitr.res.in.
Wan L LamIntegrative Oncology, British Columbia Cancer Agency, Vancouver, B.C., Canada V5Z 1L3; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, B.C., Canada V6T 2B5. Electronic address: WanLam@bccrc.ca.
William W LockwoodIntegrative Oncology, British Columbia Cancer Agency, Vancouver, B.C., Canada V5Z 1L3; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, B.C., Canada V6T 2B5. Electronic address: Wlockwood@bccrc.ca.
Levi J BeverlyJames Graham Brown Cancer Center, University of Louisville, Louisville, KY 40202; Department of Medicine, Division of Hematology and Oncology, University of Louisville School of Medicine, Louisville, KY 40202; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202. Electronic address: Levi.Beverly@Louisville.edu.
Indian Institute of Toxicology Research · INBC Cancer Agency · CAJames Graham Brown Foundation · USUniversity of British Columbia · CAUniversity of Louisville · US

Funding

Ubiquilins regulate EMT, migration and invasion of human lung cancerR01CA193220 · NCI · UNIVERSITY OF LOUISVILLE · PI BEVERLY, LEVI J · 2015 to 2019
$2.3M
Molecular Targets COBREP20GM103482 · NIGMS · UNIVERSITY OF LOUISVILLE · PI MILLER, DONALD M. · 2012 to 2012
$2.0M
CIHRNCI NIH HHS R01 CA193220NIGMS NIH HHS P20 GM103482
6 · The paper itself

Abstract

Ubiquilin (UBQLN) proteins are adaptors thought to link ubiquitinated proteins to the proteasome. However, our lab has recently reported a previously unappreciated role for loss of UBQLN in lung cancer progression. In fact, UBQLN genes are lost in over 50% of lung cancer samples examined. However, a reason for the loss of UBQLN has not been proposed, nor has a selective pressure that could lead to deletion of UBQLN been reported. Diesel Exhaust Particles (DEP) are a major concern in the large cities of developing nations and DEP exposed populations are at an increased risk of developing a number of illnesses, including lung cancer. A connection between DEP and UBQLN has never been examined. In the present study, we determined the effect of DEP on lung cell lines and were interested to determine if UBQLN proteins could potentially play a protective role following treatment with DEP. Interestingly, we found that DEP treated cells have increased expression of UBQLN proteins. In fact, over-expression of UBQLN was capable of protecting cells from DEP toxicity. To investigate the mechanism by which DEP leads to increased UBQLN protein levels, we identified and interrogated microRNAs that were predicted to regulate UBQLN mRNA. We found that DEP decreases the oncogenic microRNA, MIR155. Further, we showed that MIR155 regulates the mRNA of UBQLN1 and UBQLN2 in cells, such that increased MIR155 expression increased cell invasion, migration, wound formation and clonogenicity in UBQLN-loss dependent manner. This is the first report of an environmental carcinogen regulating expression of UBQLN proteins. We show that exposure of cells to DEP causes an increase in UBQLN levels and that MIR155 regulates mRNA of UBQLN. Thus, we propose that DEP-induced repression of MIR155 leads to increased UBQLN levels, which in turn may be a selective pressure on lung cells to lose UBQLN1.

Indexed as

Gene Expression RegulationRNA Interference3' Untranslated RegionsAdaptor Proteins, Signal TransducingAnimalsAutophagy-Related ProteinsCarrier ProteinsCell Cycle ProteinsCell Line, TumorCell MovementCell ProliferationCell Transformation, NeoplasticDisease Models, AnimalDNA Copy Number VariationsEnvironmental ExposureHeterografts3' Untranslated RegionsAdaptor Proteins, Signal TransducingAutophagy-Related ProteinsCarrier ProteinsCell Cycle ProteinsMicroRNAsMIRN155 microRNA, humanRNA, MessengerUbiquitinsUBQLN1 protein, humanUBQLN2 protein, humanVehicle Emissions

Identifiers

PMID28315615
PMCPMC5361868
OpenAlexW2596759187

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.